BioNTech SE ROE - Return on Equity 2019-2024 | BNTX

BioNTech SE return on equity for the quarter ending September 30, 2024 was -2.32.

  • BioNTech SE average return on equity for 2023 was 17.52, a 78.84% decline from 2022.
  • BioNTech SE average return on equity for 2022 was 82.81, a 40.74% decline from 2021.
  • BioNTech SE average return on equity for 2021 was 139.75, a 546.77% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

BioNTech SE ROE - Return on Equity 2019-2024 | BNTX

  • BioNTech SE average return on equity for 2023 was 17.52, a 78.84% decline from 2022.
  • BioNTech SE average return on equity for 2022 was 82.81, a 40.74% decline from 2021.
  • BioNTech SE average return on equity for 2021 was 139.75, a 546.77% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.